Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism ACKR3 modulators(atypical chemokine receptor 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 30 Jun 2022 | |
Immune System Diseases | Discovery | - | 30 Jun 2022 | |
Neoplasms | Discovery | - | 30 Jun 2022 | |
Nervous System Diseases | Discovery | - | 30 Jun 2022 | |
Obesity | Discovery | - | 30 Jun 2022 | |
Other Diseases | Discovery | - | 30 Jun 2022 | |
Renal Insufficiency | Discovery | - | 30 Jun 2022 |